Gabapentin
NDC 50228-181, Gabapentin, capsule, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-181
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-181 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN400 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-181-01 | 50228018101 | 100 CAPSULE in 1 BOTTLE, PLASTIC (50228-181-01) |
| 50228-181-05 | 50228018105 | 500 CAPSULE in 1 BOTTLE, PLASTIC (50228-181-05) |
| 50228-181-30 | 50228018130 | 30 CAPSULE in 1 BOTTLE, PLASTIC (50228-181-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/16542ee6-0e0e-4d3c-8b32-60ff6ef48846NADAC price for package 50228018101
GET /v1/drugs/nadac/50228018101NADAC price for package 50228018105
GET /v1/drugs/nadac/50228018105
Use it
Look up 50228-181 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-181 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-181. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.